Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis Stable (no update expected for reasons given in 'What's new')
Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis Stable (no update expected for reasons given in 'What's new') is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Standard Versus Biofilm Antimicrobial Susceptibility Testing to Guide Antibiotic Therapy in Cystic Fibrosis Stable (no Update Expected for Reasons Given in 'What's New')." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437546/all/Standard_versus_biofilm_antimicrobial_susceptibility_testing_to_guide_antibiotic_therapy_in_cystic_fibrosis_Stable__no_update_expected_for_reasons_given_in_'What's_new'_. Accessed 29 January 2023.
Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis Stable (no update expected for reasons given in 'What's new'). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437546/all/Standard_versus_biofilm_antimicrobial_susceptibility_testing_to_guide_antibiotic_therapy_in_cystic_fibrosis_Stable__no_update_expected_for_reasons_given_in_'What's_new'_. Accessed January 29, 2023.
Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis Stable (no update expected for reasons given in 'What's new'). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/437546/all/Standard_versus_biofilm_antimicrobial_susceptibility_testing_to_guide_antibiotic_therapy_in_cystic_fibrosis_Stable__no_update_expected_for_reasons_given_in_'What's_new'_
Standard Versus Biofilm Antimicrobial Susceptibility Testing to Guide Antibiotic Therapy in Cystic Fibrosis Stable (no Update Expected for Reasons Given in 'What's New') [Internet]. In: Cochrane Abstracts. [cited 2023 January 29]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437546/all/Standard_versus_biofilm_antimicrobial_susceptibility_testing_to_guide_antibiotic_therapy_in_cystic_fibrosis_Stable__no_update_expected_for_reasons_given_in_'What's_new'_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis Stable (no update expected for reasons given in 'What's new')
ID - 437546
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437546/all/Standard_versus_biofilm_antimicrobial_susceptibility_testing_to_guide_antibiotic_therapy_in_cystic_fibrosis_Stable__no_update_expected_for_reasons_given_in_'What's_new'_
DB - Evidence Central
DP - Unbound Medicine
ER -